Agrobiotech Stem cell treatments & regenerative medicine

 
Stem cell-based therapies are showing potential to work at the source of many diseases including diabetes, Parkinson's, Alzheimer's and certain cancers. Should the regenerative properties of stem cells be fully harnessed, there is potential to repair damaged regions of organs including the heart and brain and re-grow blood vessels. Stem cells may offer the possibility of treating disease and disability that has remained stubbornly off-limits to intervention and may now become treatable. Spinal cord damage could be corrected, and the clock could finally be wound back on neurodegenerative diseases.

Although the clinical application of stem cells can be traced back to the 1950s when the first bone marrow transplants were performed, there has been an explosion in stem cell research since then. Significant advancements in research have been made in the 15 years that have passed since the human embryonic stem cell (hESC) was first described.

Stem cell exploration has come a long way and research is ongoing, as are efforts by stem cell companies in developing novel therapies that pledge to deliver a new paradigm in medicine. However it is early days in terms of therapies reaching patients.

Stem cell therapies are part of a broader area of medicine known as regenerative medicine, which seeks to unravel the basic mechanisms of the regenerative process, enabling doctors to prevent, halt and reverse damage to vital organs due to disease, injury or genetic conditions.

Comments

Popular posts from this blog

WHAT YOU HAVE TO KNOW ABOUT...''POLLUTION AND CONTROL''

Mosquito-born zica virus Has Been Confirmed By Brazilian Health Authorities To Cause Fatal Brain-damage.

AusBiotech tells Agricultural Innovation Inquiry greater investment is needed